Consumer staples ETFs are often viewed as defensive core holdings, yet FSTA, IYK, and RSPS deliver very different exposure despite sharing the same broad sector. This comparison matters because investors evaluating sector exposure, fund performance, and relative positioning need to look beyond the labels to see what each fund actually owns. One is a broad, low-cost, market-cap index fund; another blends in healthcare and materials; and the third equalizes every position. These structural choices drive divergence in concentration risk, volatility, and returns across recent market cycles. I also checked this using Tickeron’s AI Screener to see how the holdings compare on key metrics.
FSTA is a passively managed fund tracking the MSCI USA IMI Consumer Staples 25/50 Index, providing nearly full coverage of the U.S. consumer staples market across large, mid, and small capitalizations. It holds roughly 100 stocks with a pronounced mega-cap tilt, led by WMT, COST, and PG, which together account for more than one-third of assets. Other top positions include KO, PEP, and PM. Its sector allocation is overwhelmingly consumer defensive (roughly 97–98%), with a minor consumer cyclical component. The fund's defining feature is its 0.08% expense ratio — the lowest of the three — paired with deep diversification and strong liquidity.
IYK seeks to track the Russell 1000 Consumer Staples RIC 22.5/45 Capped Index, a diversified-cap benchmark drawn from U.S. large-cap equities. It holds about 54 stocks, with top positions concentrated in PG, KO, and PM, followed by PEP and healthcare distributors MCK and CVS. This gives IYK a distinctive profile: roughly 85% consumer defensive, about 11% healthcare, and a small materials sleeve. Its expense ratio is 0.38%, notably higher than FSTA, and its top-ten concentration is elevated. Launched in 2000, it is the oldest fund in the group but offers a somewhat hybrid, less sector-pure exposure.
RSPS tracks the S&P 500 Equal Weight Consumer Staples Index, assigning each of its roughly 38 constituents an equal weight and rebalancing quarterly. Because no single name dominates, top holdings such as DLTR, TGT, and HRL each represent only about 3% of assets. The strategy deliberately dilutes the mega-cap leaders — WMT and COST carry no outsized weight — and tilts exposure toward mid-sized names. Its expense ratio is 0.40%, the highest of the trio, and its asset base is smaller, which can translate into thinner trading liquidity relative to its peers.
The consumer staples sector sits at the intersection of macro and micro forces that shape all three funds. Persistent cost-of-living pressures and cautious household spending have kept demand for food, beverages, and household products relatively resilient, supporting the defensive reputation of the group. However, pricing power is under scrutiny as consumers trade down, pressuring volumes at packaged-food and beverage companies. Regulatory and health-focused shifts — including heightened scrutiny of tobacco and processed food — weigh on select holdings such as MO and PM. Meanwhile, retail pharmacy and distribution names, which IYK includes, face margin and reimbursement headwinds. Sector risks include valuation compression, foreign-exchange drag, and slower earnings growth relative to broader equities.
Across recent months and market cycles, the three funds have diverged in ways that reflect their construction. FSTA's mega-cap concentration has generally supported trend consistency when large-quality staples outperformed, while its breadth limits single-stock drag. IYK's healthcare sleeve introduces additional factor sensitivity and has contributed to divergent relative returns versus purer staples peers. RSPS's equal weighting reduces mega-cap concentration risk but has historically lagged during periods when sector leaders drove gains, and its higher fee compounds that gap over time. Beta profiles are broadly similar and defensive, yet concentration and cost remain the primary drivers of relative positioning. From what I see, these differences become clearer when comparing the funds side by side in Tickeron’s AI Trend Prediction Engine.
When comparing funds like these, I often turn to Tickeron’s AI Screener to quickly filter holdings by sector purity, expense ratios, and concentration levels. The tool lets me apply custom screens for market-cap exposure, volatility, and performance metrics, which helps surface the structural advantages of each ETF more efficiently than manual review. It supports faster, more systematic decision-making when evaluating defensive sector options.
Based on observable structural strength, diversification profile, cost efficiency, and momentum stability, Tickeron's AI would likely favor FSTA. Its 0.08% expense ratio offers a durable cost advantage that compounds over time, while roughly 100 holdings provide the deepest diversification of the trio. Its market-cap weighting emphasizes the sector's highest-quality, most liquid franchises, and its low concentration in non-staples names keeps factor risk contained relative to IYK. While RSPS offers a thoughtful equal-weight alternative, its higher cost and narrower roster temper its risk-adjusted appeal in the current environment.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The 10-day RSI Oscillator for IYK moved out of overbought territory on October 23, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 38 instances where the indicator moved out of the overbought zone. In 31 of the 38 cases the stock moved lower in the days that followed. This puts the odds of a move down at 82%.
The Momentum Indicator moved below the 0 level on November 18, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on IYK as a result. In 61 of 86 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 71%.
The Moving Average Convergence Divergence Histogram (MACD) for IYK turned negative on November 18, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In 30 of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at 70%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IYK declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 74%.
IYK broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
The 10-day moving average for IYK crossed bullishly above the 50-day moving average on October 16, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 72%.
Following a +1.76% 3-day Advance, the price is estimated to grow further. Considering data from situations where IYK advanced for three days, in 266 of 337 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.
The Aroon Indicator entered an Uptrend today. In 229 of 305 cases where IYK Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 75%.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows